Lubiprostone: In Constipation-Predominant Irritable Bowel Syndrome

Author： Carter Natalie J.   Scott Lesley J.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.9, 2009-06, pp. : 1229-1237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome

By Camilleri Michael  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1151-1160

Informa Healthcare

Access to resources Recommend Favorite

Crofelemer is promising for the treatment for patients with diarrhoea-predominant irritable bowel syndrome

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Tegaserod: A Review of its Use in the Management of Irritable Bowel Syndrome with Constipation in Women

By Wagstaff A.J.   Frampton J.E.   Croom K.F.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1101-1120

Adis International

Access to resources Recommend Favorite

Tegaserod: a promising option in women with irritable bowel syndrome with constipation

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 6, 2004-06 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation

By Rothstein Robin D   Friedenberg Frank K  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 15, 2013-10 ,pp. : 2125-2132

Informa Healthcare

Access to resources Recommend Favorite